chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CAN NOT FUNCTION; FEELING VERY TIRED AND EXTREMELY WORN OUT; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced can not function, and feeling very tired and extremely worn out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feeling very tired and extremely worn out and can not function was not reported. This report was non-serious. This case, from the same reporter is linked to 20220760444.
lymphadenopathy in her cervical area; This is a spontaneous report from a contactable consumer (parent). A female patient of an unspecified age (reported as 59, unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient noticed lymphadenopathy in her cervical area yesterday (23Dec2020). Outcome of event was unknown.  Follow-up attempts are completed. The following information on the batch number has been requested.
Vial was initially stored in the refrigerator on 03Oct2022 and administered on 14-Nov-2022; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry/received doses after its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry/received doses after its beyond use date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 03Oct2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030g22b) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry/received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 03Oct2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry/received doses after its beyond use date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 03Oct2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry/received doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 03Oct2022 and administered on 14-Nov-2022).    Concomitant medication was not provided.  It was reported that, vial size was 2.5ml and it was initially stored in refrigerator on 03-OCT-2022.  The vial had not undergone temperature excursion.  Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-673091, US-MODERNATX, INC.-MOD-2022-672844, US-MODERNATX, INC.-MOD-2022-673082  (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2022: Follow-up received and updated patient identifiers.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-673091:Same reporter case US-MODERNATX, INC.-MOD-2022-672844:Same reporter case US-MODERNATX, INC.-MOD-2022-673082:Same reporter case
22 yo otherwise healthy m c/o general 'unwell' feelings w/ha, dizziness, mild diffuse body aches approx 24hrs after receiving j&j vaccine; Pt states has had similar reaction feelings after receiving influenza vaccine previously; Pt denies any fevers/ns/chills, rashes, cp, sob, dyspnea, abd pain/cramping/nvd.
Client declined deltoid injection due to arm pain and vaccine was administered in left thigh using a 1 inch needle intended for deltoid  Client weighs 148 lb
experiencing hives after getting the first dose; This is a spontaneous report from a Pfizer Sponsored program. A contactable female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On unspecified date, the caller (name) is experiencing hives after getting the first dose. Offer to cold transfer to DSU, but the caller wanted to callback instead. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Death Acute blood loss anemia Pleural effusion  GI bleed NSTEMI (non-ST elevated myocardial infarction)
Total vaccine failure.   Fully vaccinated and ended up with covid and It wasn?t a ?milder case?, either.    It seems antibody dependent enhancement is working well.
Left side of neck pain radiates to upperside of her head; Welts around her jaw; swollen lymph nodes on left side of neck, behind Ossicle Bone; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Left side of neck pain radiates to upperside of her head), URTICARIA (Welts around her jaw), LYMPHADENOPATHY (swollen lymph nodes on left side of neck, behind Ossicle Bone) and CHILLS (Chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced NECK PAIN (Left side of neck pain radiates to upperside of her head), URTICARIA (Welts around her jaw), LYMPHADENOPATHY (swollen lymph nodes on left side of neck, behind Ossicle Bone) and CHILLS (Chills). On 12-Feb-2021, LYMPHADENOPATHY (swollen lymph nodes on left side of neck, behind Ossicle Bone) had resolved. At the time of the report, NECK PAIN (Left side of neck pain radiates to upperside of her head), URTICARIA (Welts around her jaw) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Developed COVID19 symptoms; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Developed COVID19 symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (Developed COVID19 symptoms). On 22-Mar-2021, COVID-19 (Developed COVID19 symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered COVID-19 (Developed COVID19 symptoms) to be not applicable.    Concomitant medications was not provided.  Treatment information was not provided.
Went from a healthy person walking 4 miles per day and coaching sports to 24/7 dyspnea. heart palpitations, burning chest which extends down to elbows and knees during flare ups.
Monday-second day after=started to feel more sick, scratchy/sore throat; scratchy/sore throat; Monday-second day after=started to feel more sick, scratchy/sore throat/scratchy throat; Chest heaviness/tightness-slightly short of breath/chest tightness; Chest heaviness/tightness-slightly short of breath; Muscle aches; Minor chills; Headache; Sunday-first day after=just felt lousy, fatigue/fatigue; General malaise/ just felt lousy; Saturday night= extremely sore arm (lasted for first 24-48 hrs after); This is a spontaneous report from a contactable nurse. A 32-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL1284), intramuscular on the left arm at the age of 32 years, on 23Jan2021 11:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included eczema and allergy to metals from an unknown date and unknown if ongoing. Concomitant medication included sertraline hydrochloride (ZOLOFT). The patient received the first dose on 02Jan2021. On Saturday night (23Jan2021), the patient's had extremely sore arm (lasted for first 24-48 hrs. Then on Sunday( 24Jan2021), patient just felt lousy and fatigue. On Monday (25Jan2021), patient started to feel more sick, scratchy/sore throat, fatigue, chest heaviness/tightness lightly short of breath, muscle aches, minor chills, headache. On Tuesday, third day after, muscle aches, headache, fatigue, general malaise, scratchy throat, chest tightness. No treatment was received for the events. The outcome of the events was recovering.
Pain in the arm I got the shot; Fever; Severe headache; Severe chills and shaking; Severe chills and shaking; Nausea; Vomiting; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 13Apr2021 at 13:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 22:00, the patient experienced pain in the arm he got the shot, fever, severe headache, severe chills and shaking, nausea, vomiting and muscle pain. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in the arm he got the shot, fever, severe headache, severe chills and shaking, nausea, vomiting and muscle pain was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Seizure changed to drop attacks 2 days after shot he has not had any relief since.
Patient stated he has "nerve pain" in arm and believes the vaccinator hit a nerve during administration. He reports that pain at the injection site started immediately. He does not recall if swelling occurred, stating "possibly" when asked. He said that he now has limited use of his left arm and is unable to comfortably lay on it. He said it is particularly painful when he tries to raise it, and it takes considerable effort to do so. He was unable to describe the pain, even when given names and descriptions of types of pain, and stated "it just hurts." He states that he has not sought treatment; however, another employee said that he told her he had previously been seen in the Emergency Department for it. He states that the pain is ongoing and has not resolved as of my conversation with him on 11/21/2022. He had to cut that conversation short and stated that he would call back to finish it. He has not called back as of yet.
Varicella like eruption commencing 7 days after administration of varicella vaccine.
Moderna COVID- 19 Vaccine: Patient reported nausea, dizziness, lightheadedness soon after receiving vaccination. Vital signs stable except for blood pressure 162/87 mmHg. Patient observed and offered water and juice. No rash, respiratory symptoms, loss of consciousness, or gastrointestinal symptoms reported. Repeat vital signs all within normal ranges. Symptoms resolved, no new symptoms developed, and patient left vaccine clinic in stable condition.
Developed red splotchy rash on right ankle. Rash has spread to thighs, backs of legs, shoulder blades, arm pits and tops of the arms. Rash  also itches.
cold sores; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (cold sores) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Cold sores.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ORAL HERPES (cold sores). At the time of the report, ORAL HERPES (cold sores) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Patient received the vaccine at 12:30pm  she was going to watch her spouse get the vaccine and after he received it she passed out and tensed up  at about 12:35pm.  The vaccine was administered by the intern.  I was called into the counselling room where I saw the patient on the floor.  Intern had used a little smelling salts for the patient.  She felt better and wanted to sit up because she wanted a drink.  She was clammy and sweaty.  Her husband put her in the chair then went to get her some apple juice.  when he left she told me she felt nauseous so I gave her the trash can, then her head fell back and she tensed up and passed out so I placed her on the floor and we called 911. Patient came too and we put cold cloths on her again, took her BP which was 115/79 and her pulse was 79.  Her blood sugar was 135 and her O2 was 95.  When the paramedics got here they took her to the hospital
Information has been received from a physician's assistant concerning a female patient who was vaccinated intramuscularly with three doses of GARDASIL (lot#s not reported) with schedule as 2 months, 4 months and 6 months. On an unknown date, the patient came back for Papanicolaou test and it presented with C1N1. Unspecified medical attention was sought. At the time of this report, the patient's outcome was not reported. This is one of several reports from the same source. Additional information has been requested.
A non-serious spontaneous report of administration of expired product was received from a health professional concerning a seven-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 02-Feb-2011. The patient received the expired FLUMIST on 04-Feb-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information was received on 23-Mar-2011: Reported confirmed that there was no late occurrence of adverse events.
debilitating; continuous headache; intermittent chills; Body aches; fatigue; malaise; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic back pain and compromised immune system due to liver transplant. Concomitant medications included entecavir monohydrate (ENTECAVIR), tacrolimus (MANUFACTURER UNKNOWN), oxycodone (MANUFACTURER UNKNOWN) and morphine sulphate (MANUFACTURER UNKNOWN) for unknown indications. The patient had a history of allergy to bee stings. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 20Mar2021 at 07:00, the patient experienced debilitating, continuous headache for 7 straight days, intermittent chills/sweats, body aches, fatigue and malaise. Adverse events had resulted in doctor or other healthcare professional office/clinic visit. The patient had not received any therapeutic measures for the adverse events. The clinical outcome of the events debilitating, continuous headache for 7 straight days, intermittent chills/sweats, body aches, fatigue and malaise was resolving.  No follow-up attempts are needed. No further information is expected.
Started with high fever 104.7 then my son started acting differently. He then became lethargic and shook a little I then rushed him to the ER
Fevers reaching 104 degrees for three days in a row, fever subsided and then developed a rash on her forehead, face, neck, back and belly. Rash was raised small bumps.  Rash lasted approximately 24-36  hours.  Still remains extremely tired and fussy. Not at all like her normal self a week later.
Localized injection site reaction - red, tender patch 3in in diameter directly above injection site.  Patient described it as itchy and warm to the touch.
Port wine birthmark has faded to almost gone; Port wine birthmark has faded to almost gone; Bad struggled to sleep; Pain in upper arm that radiate to back; Fever; Headache; Bodyache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MELANOCYTIC NAEVUS (Port wine birthmark has faded to almost gone), BACK PAIN (Pain in upper arm that radiate to back), SLEEP DISORDER (Bad struggled to sleep), THERAPEUTIC RESPONSE UNEXPECTED (Port wine birthmark has faded to almost gone) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine since 1990. Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE (OSTEO BI-FLEX [CHONDROITIN SULFATE;GLUCOSAMINE HYDROCHLORIDE]) for Discomfort in joints, ESTRADIOL for Hormone replacement therapy, MULTIVITAMIN [VITAMINS NOS] for Multi-vitamin maintenance, CALCIUM for Supplementation therapy.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MELANOCYTIC NAEVUS (Port wine birthmark has faded to almost gone), BACK PAIN (Pain in upper arm that radiate to back), SLEEP DISORDER (Bad struggled to sleep), THERAPEUTIC RESPONSE UNEXPECTED (Port wine birthmark has faded to almost gone), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Bodyache) and NAUSEA (Nausea). At the time of the report, MELANOCYTIC NAEVUS (Port wine birthmark has faded to almost gone), BACK PAIN (Pain in upper arm that radiate to back), THERAPEUTIC RESPONSE UNEXPECTED (Port wine birthmark has faded to almost gone), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Bodyache) and NAUSEA (Nausea) had resolved and SLEEP DISORDER (Bad struggled to sleep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pain assessment (1-10): 8 (abnormal) 8.         Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-065652 (Patient Link).
Swollen feet 3 weeks after 1st dose and 1 week after second dose.  Lasted for three days.; This is a spontaneous report from a contactable consumer. A 58-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27May2021 11:30 (Batch/Lot Number: EW0191) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in Arm Left on 24Jun2021 11:15 (Batch/Lot Number: EW0181) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included asthma, Sulfa antibiotics, DCIS. The patient is not pregnant. Facility where the most recent COVID-19 vaccine was administered: Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior the vaccination the patient was not diagnosed with COVID-19. The patient has not been tested for COVID-19. The patient's concomitant medications were not reported. ON 17Jun2021, the patient experienced Swollen feet 3 weeks after 1st dose and 1 week after second dose.  Lasted for three days. The patient did not receive treatment for the event. The outcome of the event was recovered on an unspecified date in Jun2021.
Chest pain started in the morning after vaccination, it was a dull, achy pain with shortness of breath. Next came headaches the chest pain was uncomfortable for over 20 days
Pt recv vax on 1/12/98; on 2/24/98 pts lab results indicated a lack of response.
Sleepiness. Can sleep for two sessions in a row most days. Feel fatigued every day, most of the day, if not all day.
Patient first called the evening of the 6th complaining of swelling and redness and injection site and was told to take some Benadryl and Tylenol to help counteract the reaction, and if not better to come in and see us. Patient observed swelling at injection site of left arm, which wrapped around the inside of the arm close to the elbow. Area was was sensitive to touch and very warm. Patient was advised to go to urgent care after showing both pharmacists on duty around 5:00 pm on the 7th, the reaction occurring. The patient was seen by Urgent Care diagnosed with an allergic-type reaction and given several medications to counteract the reaction. New prescriptions were brought into the pharmacy for a Medrol Dose Pk, Loratadine 10mg, and Famotidine 20mg, and Cephalexin 500mg, and a line was drawn below the swelling and told if rash goes beyond the line,  she needs to go to the emergency room.